Fundraising Fox

Neumora Therapeutics

NASDAQ: NMRA

Watertown, US · Founded 2019 · Incorporated in Delaware · 7 known investors

neumoratx.com ↗

Neumora is a clinical research company developing investigational medications, with a focus on conducting clinical trials to obtain regulatory approval and make treatments available to patients.

BiotechDeep TechDigital HealthMedical Devicesin /neumora@NeumoraTx

Founders & leadership

KB
Kristina BurowDirector
MF
Matthew FustDirector
RN
Robert NelsenDirector
KS
Kari StefanssonDirector
PB
Paul BernsExecutive Officer, Director
SW
Stacie WeningerDirector
JP
Joshua PintoExecutive Officer
MH
Maykin HoDirector
AH
Alaa HalawaDirector
TT
Tamara TompkinsExecutive Officer

Investors · 7

ARCH Venture PartnersChicago · $50K – $250M
Catalio Capital Management, LPNew York
F-Prime Capital PartnersCambridge · $3M – $10Mvia Stacie Weninger · board
K2 HealthVenturesBoston · $10M – $100M
Mercury FundHouston · $250K – $4M
Premier PartnersSeoul
Newpath PartnersreportedBoston · $50K – $10M

Reported raises · per SEC filings

Form D private placements
▶$474.4MraisedJan 2023 · 124 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kristina BurowDirector
  • Matthew FustDirector
  • Robert NelsenDirector
  • Kari StefanssonDirector
  • Paul BernsExecutive Officer, Director
  • Stacie WeningerDirector
  • Joshua PintoExecutive Officer
  • Maykin HoDirector
  • Alaa HalawaDirector
  • Tamara TompkinsExecutive Officer
Offering amount
$474.4M
Amount sold
$474.4M
First sale
Sep 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news